MYO
$0.72
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally.
Recent News
Elevance Expands Myomo Coverage To Support Tech Enabled Care Narrative
Elevance Health (NYSE:ELV) entered into new network participation agreements with Myomo. The agreements expand coverage for advanced orthotic devices to tens of millions of Elevance members. Coverage spans commercial, Medicare Advantage, and Medicaid plans, adding to Elevance's technology-enabled care offerings. For you as an investor, this move speaks directly to how Elevance Health is shaping its core health benefits business around technology-enabled, patient-centered care. The Myomo...
Myomo Inc (MYO) Q4 2025 Earnings Call Highlights: Record Revenue Amid Rising Expenses and ...
Despite achieving its highest revenue quarter, Myomo Inc (MYO) faces increased operating losses and outlines strategic initiatives for future growth.
Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates
Myomo (MYO) delivered earnings and revenue surprises of +5.88% and +11.86%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Cresco Labs Inc. (CRLBF) Reports Q4 Loss, Beats Revenue Estimates
Cresco Labs Inc. (CRLBF) delivered earnings and revenue surprises of +14.16% and +0.26%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Myomo Inc (MYO) Q3 2025 Earnings Call Highlights: Strong International Growth Amidst Domestic ...
Myomo Inc (MYO) reports robust revenue growth in Germany, but faces domestic hurdles with decreased margins and increased operating expenses.